NCT01224834View on ClinicalTrials.gov

Safety and Tolerability Study of Ragweed SLIT Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

April 30, 2009

Study Completion Date

October 31, 2009

Conditions

Rhinitis, Allergic, SeasonalRagweed Pollen Allergy

Interventions

DRUG

Sublingual tablet of ragweed pollen allergen extract

administered once a day over 10 days

Trial Locations (1)

H-8230

DRC Drug Research Center, Balatonfüred

Sponsors

Lead Sponsor

Stallergenes Greer

All Listed Sponsors

collaborator

Quintiles, Inc.

INDUSTRY

lead

Stallergenes Greer

INDUSTRY